Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29 SEK | +1.22% | -2.36% | +21.34% |
Sales 2023 | 1.41M 1.5M 16.38M | Sales 2024 * | 3.6M 3.83M 41.89M | Capitalization | 705M 752M 8.21B |
---|---|---|---|---|---|
Net income 2023 | -23M -24.5M -268M | Net income 2024 * | -36M -38.35M -419M | EV / Sales 2023 | 369 x |
Net cash position 2023 | 87.92M 93.66M 1.02B | Net cash position 2024 * | 50.95M 54.27M 593M | EV / Sales 2024 * | 182 x |
P/E ratio 2023 |
-6.31
x | P/E ratio 2024 * |
-3.95
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 4.86% |
Latest transcript on Implantica AG
1 day | +1.22% | ||
1 week | -2.36% | ||
Current month | -7.35% | ||
3 months | +5.07% | ||
6 months | +62.92% | ||
Current year | +21.34% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Forsell
CEO | Chief Executive Officer | 70 | 14-12-31 |
Andreas Öhrnberg
DFI | Director of Finance/CFO | 46 | 19-12-31 |
Director/Board Member | 67 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tomas Puusepp
BRD | Director/Board Member | 69 | 19-12-31 |
Liselott Kilaas
CHM | Chairman | 65 | 19-12-31 |
Johan Bojs
BRD | Director/Board Member | 60 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 29 | +1.22% | 11,452 |
24-04-18 | 28.65 | -0.87% | 15,501 |
24-04-17 | 28.9 | -2.36% | 16,904 |
24-04-16 | 29.6 | -1.00% | 17,945 |
24-04-15 | 29.9 | +0.67% | 45,726 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.34% | 742M | |
+72.65% | 12.28B | |
-19.41% | 7.81B | |
+14.98% | 7.19B | |
-5.13% | 5.23B | |
+5.78% | 4.94B | |
+17.02% | 4.24B | |
-25.36% | 3.97B | |
-40.56% | 2.24B | |
-3.47% | 1.92B |
- Stock Market
- Equities
- IMP A SDB Stock